Related Experiment Videos
Srcasm modulates EGF and Src-kinase signaling in keratinocytes
Weijie Li1, Christine Marshall, Lijuan Mei
1Department of Dermatology, University of Pennsylvania Medical School, 415 Curie Blvd., Philadelphia, PA 19104, USA.
The Journal of Biological Chemistry
|December 8, 2004
Summary
Srcasm protein activates Src-family kinases (SFKs) and enhances epidermal growth factor (EGF) signaling in skin cells. This molecule influences cell growth and differentiation, and its levels are reduced in skin cancer.
Area of Science:
- Cellular signaling
- Molecular biology
- Cancer research
Background:
- Srcasm is a novel activator and substrate of Src-family tyrosine kinases (SFKs).
- Its precise role in cellular signaling pathways remains largely uncharacterized.
Purpose of the Study:
- To investigate the role of Srcasm in epidermal growth factor (EGF) receptor signaling in keratinocytes.
- To elucidate the functional consequences of Srcasm modulation on cellular processes like proliferation and differentiation.
Main Methods:
- Utilized keratinocytes to study endogenous and transduced Srcasm.
- Investigated tyrosine phosphorylation, SFK activation, and downstream signaling pathways (MAPK, Elk-1).
- Assessed effects of Srcasm on keratinocyte proliferation and differentiation; analyzed Srcasm levels in human cutaneous neoplasia.
Main Results:
- EGF receptor ligands induce Srcasm tyrosine phosphorylation, which in turn activates SFKs (Fyn and Src).
- Srcasm potentiates EGF-dependent SFK signaling, enhancing MAPK activity and Elk-1 transcription.
- Elevated Srcasm inhibits keratinocyte proliferation but promotes differentiation; Srcasm levels are decreased in skin cancers.
Conclusions:
- Srcasm acts as a crucial link between EGF receptor and SFK signaling pathways in keratinocytes.
- Srcasm plays a significant role in regulating keratinocyte differentiation.
- Reduced Srcasm expression is associated with human cutaneous neoplasia, suggesting a potential tumor suppressor role.